You are here

patents

Generics companies face risk as SCOTUS questions patent tribunal’s constitutionality

MedCity News

Fri, 03/5/21 - 10:24 am

AstraZeneca breathes sigh of relief as court blocks US Symbicort generic

Pharmaforum

Wed, 03/3/21 - 10:17 am

Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too

Endpoints

Fri, 02/12/21 - 10:48 am

What does Brexit mean for biopharma companies?

Biopharma Reporter

Tue, 02/9/21 - 01:06 pm

Which pharmaceutical drugs have the most patents?

Drug Patent Watch

Sun, 01/24/21 - 03:16 pm

Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead

Fierce Pharma

Tue, 01/19/21 - 09:18 pm

Gilead Sciences

Amarin vs. the Generics: Who Will Win?

Motley Fool

Sun, 11/22/20 - 11:55 pm

Major generic makers will partner with Medicines Patent Pool to pursue voluntary licenses for Covid-19 drugs

Stat

Wed, 11/11/20 - 11:46 pm

Testing requirements are likely slowing biosimilar entries in the US

RAPS.org

Wed, 10/14/20 - 05:53 pm

Covid-19 Vaccine Frontrunner Moderna Won’t Enforce Vaccine Patents During Pandemic

Forbes

Thu, 10/8/20 - 10:52 am

Moderna Therapeutics

Teva back on the hook for $235M to GSK for heart drug infringement

Fierce Pharma

Mon, 10/5/20 - 11:42 pm

Patent Infringement

Medtronic Takes the Gloves Off in Patent War with Axonics

Medical Devices and Diagnostics Industry

Sat, 09/26/20 - 10:23 pm

sacral neuromodulation

Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire

Endpoints

Fri, 09/4/20 - 12:04 am

Amarin Patent Appeal Is a Coin Toss With Billions on the Line

Yahoo/Bloomberg

Wed, 09/2/20 - 11:07 am

AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman

Fierce Pharma

Tue, 09/1/20 - 12:28 pm

Moderna failed to disclose federal funding for vaccine patent applications, advocates say

Stat

Sun, 08/30/20 - 12:02 am

Moderna Therapeutics

Department of Defense

U.S. court upholds patent for Novartis MS drug Gilenya

Reuters

Tue, 08/18/20 - 11:04 am

multiple sclerosis

Bristol Myers, Pfizer fend off a key challenge to their top-selling heart drug

BioPharma Dive

Thu, 08/6/20 - 10:27 am

Bristol-Myers Squibb

Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

CP Wire

Mon, 08/3/20 - 10:17 am

Chelation Partners

antibiotic resistance

Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections

Mon, 08/3/20 - 09:59 am

Chelation Partners

antibiotic resistance

Pages